BioLife Solutions to Report Fourth Quarter and Full Year 2024 Financial Results and Business Update on March 3, 2025

Rhea-AI Summary

BioLife Solutions (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy market, has scheduled its fourth quarter and full year 2024 financial results release for March 3, 2025, before market open.

The company will host a conference call and webcast at 8:00am ET (5:00am PT) on the same day, where management will present financial results and provide a business update. Investors can access the webcast through BioLife's website or join via phone using the toll-free number 1-833-630-0431 (international: 1-412-317-1808). A replay will be available approximately two hours after the call and remain accessible for 90 days on the investor relations website.

BOTHELL, Wash., Feb. 20, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction products and services for the cell and gene therapy ("CGT") market, today announced the 2024 fourth quarter and full year financial results will be released on March 3, 2025 pre-market. The Company will host a conference call and live webcast at 8:00am ET (5:00am PT) that day. Management will provide an overview of the Company's financial results and give a general business update.

To access the webcast, log onto the Investor Relations page of the BioLife Solutions website at https://www.biolifesolutions.com/earnings. In addition, the conference call will be accessible by dialing toll-free 1-833-630-0431 or 1-412-317-1808 for international callers.  A webcast replay will be available approximately two hours after the call and will be archived on https://investors.biolifesolutions.com for 90 days.

About BioLife Solutions
BioLife Solutions is a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and broader biopharma markets. Our expertise facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, storage, and distribution. For more information, please visit www.biolifesolutions.com or follow BioLife on LinkedIn and X.

Media & Investor Relations

At the Company
Troy Wichterman
Chief Financial Officer
(425) 402-1400
twichterman@biolifesolutions.com

Investors
Alliance Advisors IR
Jody Cain
(310) 691-7100
jcain@allianceadvisors.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/biolife-solutions-to-report-fourth-quarter-and-full-year-2024-financial-results-and-business-update-on-march-3-2025-302381744.html

SOURCE BioLife Solutions, Inc.

FAQ

When will BioLife Solutions (BLFS) release Q4 and full year 2024 earnings?

BioLife Solutions will release its Q4 and full year 2024 financial results on March 3, 2025, before the market opens.

What time is BioLife Solutions (BLFS) Q4 2024 earnings call?

BioLife Solutions' Q4 2024 earnings call is scheduled for March 3, 2025, at 8:00am ET (5:00am PT).

How can investors access BioLife Solutions (BLFS) Q4 2024 earnings call?

Investors can access the call via webcast on BioLife's website or by phone at 1-833-630-0431 (US) or 1-412-317-1808 (international).

How long will BioLife Solutions (BLFS) Q4 2024 earnings call replay be available?

The webcast replay will be available approximately two hours after the call and will be archived for 90 days on BioLife's investor relations website.